Many aspects of intravascular lipid transport and lipoprotein metabolism are exquisitely sensitive to the influence of circulating hormones. A rational clinical approach to the commonly encountered hyperlipidemias requires a thorough understanding of endocrine regulating mechanisms. Control points that may be relevant to pharmacotherapy are discussed.
No takes yet. Share an insight, caveat, or question.
Richard B. Weinberg (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: